Chaomei He
VP and Head of CMC at Kira Pharmaceuticals
- Role
- VP and Head of Cmc at Kira Pharmaceuticals
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Chaomei He
Chaomei He has broad experiences in the biotechnology and pharmaceutical industry developing biologics and biosimilars from R&D, early and late development and manufacturing. An expert in CMC development, CMC strategy, CMO/CRO management and regulatory submissions, Chaomei was previously an Associate Director at Momenta Pharmaceuticals, leading manufacturing cell line development efforts for all of Momenta’s new drug and biosimilar pipelines including M281, M230 and M710. She also served as CMC lead for several programs and was CMC regulatory lead for the M254 program. Currently, she is a VP and Head of CMC at Kira Pharmaceuticals, spearheading IND-enabling CMC development and manufacturing for Kira’s most advanced program P014, delivering DNA to IND submission in ~18 months.
Experience
VP and Head of Cmc
Feb 2020 — Present · Cambridge, MA, US
Education
Boston University
Chemistry
1987 — 1994
Skills
- Monoclonal Antibodies
- Assay Development
- Cell Culture
- Immunoassays
- Cell
- Recombinant Dna Technology
- Drug Discovery
- High Throughput Screening
- Drug Development
- Purification
- Biopharmaceuticals
- Elisa
- In Vitro
- Antibodies
- Biomarkers
- Protein Chemistry
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.